← Open Payments lookup

LORINDA LILES: Open Payments

NPI 1104207414 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$999 in 53 payments from 19 companies in 2025. Trend: 2023 $644 · 2024 $1,256 · 2025 $999

Food & beverage: $999
CompanyPaymentsAmount
Novartis Pharmaceuticals Corporation15$282
ANI Pharmaceuticals, Inc.4$90
Fresenius USA Marketing, Inc.4$88
OPKO Pharmaceuticals, LLC4$69
Boehringer Ingelheim Pharmaceuticals, Inc.3$60
Bayer Healthcare Pharmaceuticals Inc.3$59
Novo Nordisk Inc3$59
Travere Therapeutics, Inc.4$47
AstraZeneca Pharmaceuticals LP2$42
Aurinia Pharma U.S., Inc.2$41

Products named: Vanrafia, Fabhalta, PURIFIED CORTROPHIN GEL, VELPHORO, RAYALDEE, JARDIANCE, Kerendia, Ozempic.

Industry payments across TX — which companies pay providers there.